Yang Weibin, Dollear Mary, Muthukrishnan Sri Ranjini
Department of Neurology and Rehabilitation, University of Illinois, Chicago, IL, USA.
Arch Phys Med Rehabil. 2005 Jun;86(6):1265-6. doi: 10.1016/j.apmr.2004.11.022.
Zolpidem is an imidazopyridine agent indicated for the short-term treatment of insomnia. Sleepwalking is a rare side effect of zolpidem. A review of the literature produced only 2 cases. We report a case of a male rehabilitation inpatient in his mid fifties with a history of alcoholism and traumatic brain injury who had undergone a right hip hemiarthroplasty. He had no history of somnambulism or insomnia but walked in his sleep on 2 nonconsecutive nights after taking zolpidem. He had exhibited no such behavior before taking zolpidem, on the intervening night that was he was not given medication, and after the medication was discontinued. We conclude that zolpidem can cause sleepwalking, and patients who have suffered a brain injury may be more susceptible to this side effect. Here we describe the clinical presentation and review the relevant literature on zolpidem and sleepwalking.
唑吡坦是一种咪唑并吡啶类药物,用于短期治疗失眠。梦游是唑吡坦罕见的副作用。文献回顾仅发现2例相关病例。我们报告一例五十多岁的男性康复住院患者,有酗酒和创伤性脑损伤史,接受过右髋关节半关节置换术。他既往无梦游或失眠病史,但在服用唑吡坦后的两个非连续夜晚出现了梦游。在服用唑吡坦之前、未服药的中间夜晚以及停药后,他均未出现此类行为。我们得出结论,唑吡坦可导致梦游,脑损伤患者可能更容易出现这种副作用。在此我们描述其临床表现,并回顾唑吡坦与梦游的相关文献。